Collegium Pharmaceutical Gains Attention on Strong ADHD Portfolio and Q1 2026 Beat TDC Q1 2026 Earnings EPS Surges Past Estimates Stock Gains 765 US Payrolls Exceed Expectations in April But Underlying Concerns Persist